BOARD OF DIRECTORS
Lewis T. “Rusty” Williams, MD, PhD
Co-founder, Chairman and CEO
Stella Xu, PhD
Managing Director, Quan Capital
Franklin Berger, MBA
FMB Research
Antonin (Tony) de Fougerolles, PhD
CEO of Evox Therapeutics
Beverly Lu, PhD
Investor, Yosemite
Abhijit “Ron” Mazumder, PhD, MBA
Partner, Illumina Ventures
Steve Liapis, PhD
Principal, Northpond Ventures
Manish Kothari, PhD
Founding Partner, First Spark Ventures
SCIENTIFIC ADVISORY BOARD
Chris Allen, PhD (UCSF): B cell engineering
Malcolm Brenner, MD (Baylor): Cell and gene therapy
Tullia Bruno, PhD (University of Pittsburgh): B cell biology
David Curiel, MD, PhD (Washington University): Adenoviral engineering expert
Ronald Levy, MD (Stanford University): Cancer immune therapy; intratumoral injection approaches
Michel Nussenzweig, MD, PhD (HHMI, Rockefeller University): B cell biology
James Voss, PhD (Scripps Research): B cell engineering
Kerstin Wennhold, PhD (University of Cologne): B cell homing
Julie Zikherman, MD (UCSF): B cell receptor structure and signaling